Top Markets
#1 Black Phoenix Black Phoenix +365.85%
#2 Islamic Coin Islamic Coin +158.20%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.05%
#5 Akedo Akedo +34.14%
#6 BasedHype BasedHype +29.84%
#7 Acurast Acurast +27.03%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.11%
#9 Cryptopia Cryptopia +21.42%
#10 GoPlus Security GoPlus Security +20.47%
Coin of the day
Black Phoenix Black Phoenix
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Hisse Senetlerindeki Sıralama #41146
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Hisse Fiyatı
$0.04082105
Son senkronizasyon: 2024-08-12
Piyasa Değeri
$39.09K
Değişim (1 gün)
-19.83%
Değişim (1 yıl)
0.00%
Ülke
GB
Ticaret Destiny Pharma plc (DEST)

Kategori

Healthcare
Destiny Pharma plc (DEST) için P/S oranı
August 2026 itibarıyla P/S oranı TTM: 3.46
Destiny Pharma plc şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 3.46'dir. 2022 yılının sonunda şirketin P/S oranı 243.09 idi.
Destiny Pharma plc için P/S oranı geçmişi 2013 - 2026 arası
Her yılın sonunda P/S oranı
Yıl P/S Oranı Değiştir
2026 (TTM) 3.46 -95.47%
2023 76.33 -68.60%
2022 243.09 -47.78%
2021 465.54 -81.29%
2020 2.49K 3,941.09%
2019 61.58 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
Benzer şirketler veya rakipler için P/S oranı
Şirket P/S Oranı P/S Oranı Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 185.98%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 198.20%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 44.11%
BE